Published in
Nature Research, Nature Communications, 1(6), 2015
DOI: 10.1038/ncomms9479
Links
- ORCID
- ORCID
- ORCID
- Nature Research | PDF
- ORCID
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [repositori.upf.edu] | PDF
- [air.unimi.it] | PDF
- [uu.diva-portal.org] | PDF
Tools
The alternative splicing factor Nova2 regulates vascular development and lumen formation
,
Daniel Nyqvist ,
Valeria Quaranta,
Stefano Confalonieri,
Giovanni Bertalot ,
Fabrizio Orsenigo ,
Federica Pisati,
Elisabetta Ferrero,
Giuseppe Biamonti
and other authors.
Full text: Download
Abstract
AbstractVascular lumen formation is a fundamental step during angiogenesis; yet, the molecular mechanisms underlying this process are poorly understood. Recent studies have shown that neural and vascular systems share common anatomical, functional and molecular similarities. Here we show that the organization of endothelial lumen is controlled at the post-transcriptional level by the alternative splicing (AS) regulator Nova2, which was previously considered to be neural cell-specific. Nova2 is expressed during angiogenesis and its depletion disrupts vascular lumen formation in vivo. Similarly, Nova2 depletion in cultured endothelial cells (ECs) impairs the apical distribution and the downstream signalling of the Par polarity complex, resulting in altered EC polarity, a process required for vascular lumen formation. These defects are linked to AS changes of Nova2 target exons affecting the Par complex and its regulators. Collectively, our results reveal that Nova2 functions as an AS regulator in angiogenesis and is a novel member of the ‘angioneurins’ family.